510(k) Report

510(k) · Cleared

Cleared

Eecp Therapy System Model TS3 with Pulse Oximetry and Enhanced External Counterpulsation Eecp MC-2 External Counter

K020857510(k) TraditionalCleared Jun 14, 200288-day reviewClass II21 CFR 870.5225

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vasomedical, Inc. · DRN Device, Counter-Pulsating, External

Cleared on Jun 14, 2002 as substantially equivalent to K003469 (Vasomedical, Inc., 2000) and 1 other predicate after an 88-day review. Its family tree reaches back 1 generation to 1995. 7 later devices descend from it.

Decided
Jun 14, 2002
Review
88 days
Class
Class II
Product code
DRN
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K940264 (1995). 2 ancestors in all. 7 later devices descend from it, 5 citing it directly.

Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 5 descendants2 generations forward: 2 descendants K940264 · Vasogenics Eecp-MC2 · Vasogenics, Inc. · 19950
  1. Root · 1 generation backK940264 Vasogenics Eecp-MC2Vasogenics, Inc. · 1995
  2. This deviceK020857 Eecp Therapy System Model TS3 with Pulse Oximetry and Enhanced…Vasomedical, Inc. · 2002
  3. Descendant · cites it directly · 3 of its ownK022107 Cardiassist Counterpulsation System, Model Mark 3000Cardiomedics, Inc. · 2002
  4. Descendant · cites it directly · 1 of its ownK023701 Angionew-IVLiving Data Technologies Corporation · 2003
  5. Descendant · cites it directly · 1 of its ownK023427 Cardiassist Counterpulsation System, Model Mark 3000Cardiomedics, Inc. · 2003
  6. Descendant · cites it directly · 0 of its ownK082134 Circulator BootCirculator Boot Corp. · 2009
  7. Descendant · 2 generations on · 0 of its ownK050172 Cardiassist Counter Pulsation System Series 4000/5000Cardiomedics, Inc. · 2005 · Recalled

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2002: 12003: 32004: 12005: 12009: 1
2002high 3 (2003) · low 0 (2006)2026

Most influential descendants

Showing 5 of 7 · See all
  • K022107Cardiassist Counterpulsation System, Model Mark 3000Cardiomedics, Inc. · 2002 · cites it directly3descendants
  • K023701Angionew-IVLiving Data Technologies Corporation · 2003 · cites it directly1descendant
  • K023427Cardiassist Counterpulsation System, Model Mark 3000Cardiomedics, Inc. · 2003 · cites it directly1descendant
  • K082134Circulator BootCirculator Boot Corp. · 2009 · cites it directly0descendants
  • K050172Cardiassist Counter Pulsation System Series 4000/5000Cardiomedics, Inc. · 2005 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K940264Vasogenics Eecp-MC2Vasogenics, Inc.1995—
0 (this device)K020857Eecp Therapy System Model TS3 with Pulse Oximetry and Enhanced External…Vasomedical, Inc.2002—
+1K022107Cardiassist Counterpulsation System, Model Mark 3000Cardiomedics, Inc.2002—
+1K023701Angionew-IVLiving Data Technologies Corporation2003—
+1K023427Cardiassist Counterpulsation System, Model Mark 3000Cardiomedics, Inc.2003—
+1K082134Circulator BootCirculator Boot Corp.2009—
+2K050172Cardiassist Counter Pulsation System Series 4000/5000Cardiomedics, Inc.20051

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200210
200330
200410
200510
200910
FIG. 1 — Lineage of K020857, 1995–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DRN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DRN device

  1. #1 K250756 Pression Wave PRO External Counter-Pulsation…score 10.8 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K003469Eecp Therapy System, Model TS3
Summary page 1
…EECP@Therapy System Model TS3 with Pulse Oximetry is substantially equivalent to the EECP@Therapy System Model TS3 (K003469) and, by reference, to the EECP@MC-2 (K940264). 6. Device Description: The EECP" Therapy System…
Vasomedical, Inc.2000—
*K940264Vasogenics Eecp-MC2
Summary page 1
…try is substantially equivalent to the EECP@Therapy System Model TS3 (K003469) and, by reference, to the EECP@MC-2 (K940264). 6. Device Description: The EECP" Therapy System Model TS3 with Pulse Oximetry is comprised of…
Vasogenics, Inc.1995—
†K982969Nonin Pulse Oximeter and Carbon Dioxide Detector, Models 9843, 9845 and 9847Nonin Medical, Inc.1999—
†K9827769303 Neonatal/Adult Vital Signs MonitorCas Medical Systems, Inc.1998—
†K970763Modular Telemetry System (MTS) Option for the Mde Escort II MonitorMedical Data Electronics1997—
†K002690Model 2500, Palmsat Hand Held Pulse Oximeter, Model 2500Nonin Medical, Inc.20002

What descends from it? (7)

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K022107Cardiassist Counterpulsation System, Model Mark 3000Cardiomedics, Inc.20023
K023701Angionew-IVLiving Data Technologies Corporation20031
K023427Cardiassist Counterpulsation System, Model Mark 3000Cardiomedics, Inc.20031
K082134Circulator BootCirculator Boot Corp.20090
K033617Eecp Therapy System Model TS4 with/Without Pluse OximetryVasomedical, Inc.20040

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • Of its descendants, K022107 (Cardiomedics, Inc., 2002) has gone furthest, with 3 descendants of its own.

How does its category compare?

All DRN devices

DRN Device, Counter-Pulsating, External: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DRN

1in 2025

2008: 12009: 12013: 12015: 12018: 12019: 12020: 22025: 1
2007high 2 (2020) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DRN

Too few DRN 510(k)s in any year since 2007 to give a median.

Recalls per year · DRN

1in 2009

2009: 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DRN

1in 2024

2007: 22016: 12024: 1
2007high 2 (2007) · low 0 (2008)2025

MAUDE reports naming product code DRN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—02
20081—00
20091—10
20100—00
20110—00
20120—00
20131—00
20140—00
20151—00
20160—01
20170—00
20181—00
20191—00
20202—00
20210—00
20220—00
20230—00
20240—01
20251—00
20260—0—

What is it indicated for?

Vasomedical, Inc.’s EECP® Therapy System Model TS3 with Pulse Oximetry is a non-invasive external counterpulsation device intended for use in the treatment of patients with congestive heart failure, stable or unstable angina pectoris, acute myocardial infarction, or cardiogenic shock. Vasomedical, Inc.’s EECP® Therapy System Model TS3 is a non-invasive external counterpulsation device intended for use in the treatment of patients with congestive heart…

Read the full statement (111 words)

Vasomedical, Inc.’s EECP® Therapy System Model TS3 with Pulse Oximetry is a non-invasive external counterpulsation device intended for use in the treatment of patients with congestive heart failure, stable or unstable angina pectoris, acute myocardial infarction, or cardiogenic shock.

Vasomedical, Inc.’s EECP® Therapy System Model TS3 is a non-invasive external counterpulsation device intended for use in the treatment of patients with congestive heart failure, stable or unstable angina pectoris, acute myocardial infarction, or cardiogenic shock.

Vasomedical, Inc.’s Enhanced External Counterpulsation EECP® MC-2 is a non-invasive external counterpulsation device intended for use in the treatment of patients with congestive heart failure, stable or unstable angina pectoris, acute myocardial infarction, or cardiogenic shock.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K020857: Eecp Therapy System Model TS3 with Pulse Oximetry and Enhanced External Counterpulsation Eecp MC-2 External Counter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K020857

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026